Protalix BioTherapeutics Inc (PLX)
1.17
0.00 (0.00%)
USD |
NYAM |
Oct 31, 16:00
1.17
0.00 (0.00%)
After-Hours: 19:27
Protalix BioTherapeutics Free Cash Flow: -4.182M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -4.182M |
March 31, 2024 | 4.369M |
December 31, 2023 | -2.467M |
September 30, 2023 | -8.636M |
June 30, 2023 | -10.56M |
March 31, 2023 | -22.82M |
December 31, 2022 | -25.63M |
September 30, 2022 | -28.34M |
June 30, 2022 | -21.30M |
March 31, 2022 | -7.582M |
December 31, 2021 | -11.74M |
September 30, 2021 | -14.03M |
June 30, 2021 | -15.52M |
March 31, 2021 | -29.80M |
December 31, 2020 | -26.76M |
September 30, 2020 | -22.65M |
June 30, 2020 | -22.56M |
March 31, 2020 | -19.72M |
December 31, 2019 | -19.98M |
September 30, 2019 | -20.46M |
June 30, 2019 | -3.31M |
March 31, 2019 | -6.212M |
December 31, 2018 | -8.428M |
September 30, 2018 | 13.06M |
June 30, 2018 | -11.15M |
Date | Value |
---|---|
March 31, 2018 | -11.98M |
December 31, 2017 | -10.96M |
September 30, 2017 | -35.72M |
June 30, 2017 | -28.64M |
March 31, 2017 | -31.72M |
December 31, 2016 | -32.95M |
September 30, 2016 | -29.35M |
June 30, 2016 | -34.54M |
March 31, 2016 | -28.10M |
December 31, 2015 | -24.75M |
September 30, 2015 | -25.93M |
June 30, 2015 | -26.94M |
March 31, 2015 | -27.98M |
December 31, 2014 | -30.07M |
September 30, 2014 | -29.99M |
June 30, 2014 | -28.74M |
March 31, 2014 | -30.92M |
December 31, 2013 | -32.54M |
September 30, 2013 | -26.01M |
June 30, 2013 | -26.26M |
March 31, 2013 | -4.57M |
December 31, 2012 | -1.433M |
September 30, 2012 | -10.32M |
June 30, 2012 | -10.65M |
March 31, 2012 | -29.77M |
Free Cash Flow Range, Past 5 Years
-29.80M
Minimum
Mar 2021
4.369M
Maximum
Mar 2024
-16.31M
Average
-19.72M
Median
Mar 2020
Free Cash Flow Benchmarks
Aethlon Medical Inc | -9.395M |
Predictive Oncology Inc | -12.83M |
bluebird bio Inc | -254.20M |
AIM ImmunoTech Inc | -23.91M |
Armata Pharmaceuticals Inc | -46.08M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.61M |
Cash from Investing (Quarterly) | -0.18M |
Free Cash Flow Per Share (Quarterly) | -0.0516 |
Free Cash Flow to Equity (Quarterly) | -3.782M |
Free Cash Flow to Firm (Quarterly) | -3.782M |
Free Cash Flow Yield | -4.51% |